Compare CLLS & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLLS | VOXR |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.2M | 339.3M |
| IPO Year | 2007 | N/A |
| Metric | CLLS | VOXR |
|---|---|---|
| Price | $3.69 | $5.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | 44.3K | ★ 806.7K |
| Earning Date | 03-12-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 0.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $82,551,000.00 | $12,158,304.00 |
| Revenue This Year | $32.58 | $42.80 |
| Revenue Next Year | $20.68 | $82.76 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.04 | 9.06 |
| 52 Week Low | $1.10 | $2.21 |
| 52 Week High | $5.48 | $5.88 |
| Indicator | CLLS | VOXR |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 58.72 |
| Support Level | $3.44 | $4.77 |
| Resistance Level | $3.98 | $5.36 |
| Average True Range (ATR) | 0.21 | 0.37 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 20.28 | 73.42 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.